Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Releases Interim Analysis Results of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in the Phase 3 ORIENT-16 Study at ESMO Congress 2021 2021-09-18 08:00
Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021 2021-09-18 08:00
Luye Pharma Becomes the Marketing Authorization Holder for Seroquel and Seroquel XR in Saudi Arabia 2021-09-17 22:16
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021 2021-09-17 21:00
#WeToo launches movement to bring leading businesses and individuals into the fight against child abuse 2021-09-17 20:40
InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355 2021-09-17 20:00
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for First-Line Treatment of sqNSCLC Accepted by China's NMPA, Phase 3 MRCT Met its Primary Endpoint 2021-09-17 20:00
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021 2021-09-17 19:00
111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference 2021-09-17 19:00
Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare 2021-09-17 15:30
Vieworks to Showcase its Complete Dental Detector Lineup at IDS 2021 2021-09-17 15:00
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone 2021-09-17 15:00
CStone will present registrational clinical study data of Sugemalimab in patients with stage III non-small cell lung cancer in an oral presentation at ESMO Congress 2021 2021-09-17 08:00
Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021 2021-09-17 08:00
Arctic Vision Announces Addition of Novel Mydriatic Drug MydCombi™ (ARVN004) to Eyenovia Commercialization Deal 2021-09-17 08:00
Everest Medicines, Sinovent and SinoMab Announce Licensing Agreement for Global Development, Manufacturing and Commercialization of Novel BTK Inhibitor in Renal Diseases 2021-09-17 06:30
Bridge Biotherapeutics Presents Pre-Clinical Data of BBT-176 at the European Society for Medical Oncology (ESMO) Virtual Congress 2021 2021-09-17 06:00
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale 2021-09-17 03:59
Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus 2021-09-16 22:17
Validic Empowers Physicians and Care Managers to Manage Personal Health Data at Scale 2021-09-16 21:00
1 587 588 589 590 591 1137